About 24 percent of men who took the placebo , or 1,147 men , developed prostate cancer .
About 24 percent of men who took the placebo , or 1,147 men , developed prostate cancer .
They found that 18 percent of the men who took finasteride , or 803 men , developed prostate cancer .